Valuation: Boule Diagnostics AB

Market Cap 4Cr 40.33L 36.18L 33.45L 30.3L 56.6L 38Cr 57.29L 1.59Cr 20Cr 1.51Cr 1.48Cr 64Cr P/E 2026 *
-4.09x
P/E 2027 * 4.65x
Enterprise Value 24Cr 2.39Cr 2.14Cr 1.98Cr 1.79Cr 3.35Cr 227.15Cr 3.39Cr 9.42Cr 118.86Cr 8.95Cr 8.76Cr 377.35Cr EV / Sales 2026 *
0.52x
EV / Sales 2027 * 0.46x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day-0.19%
1 week-49.51%
Current month-55.39%
1 month-54.41%
3 months-71.57%
6 months-71.33%
Current year-78.92%
1 week 0.94
Extreme 0.944
1.95
1 month 0.94
Extreme 0.944
2.83
Current year 0.94
Extreme 0.944
5.68
1 year 0.94
Extreme 0.944
6.64
3 years 0.94
Extreme 0.944
12.62
5 years 0.94
Extreme 0.944
59.5
10 years 0.94
Extreme 0.944
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
27/02/23 Buy

Chief Financial Officer

8,000 0.0206%
06/02/23 Buy

Director

7,083 0.0182%
17/02/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+0.49%-49.51%-83.14%-88.75% 40.33L
+0.82%+4.76%+26.94%+63.26% 26TCr
+1.31%+3.21%+10.80%+28.10% 16TCr
+0.75%+0.72%-16.84%+72.94% 15TCr
-1.32%-8.48%-58.02%-15.86% 6.15TCr
+3.10%+4.94%+14.33%+51.60% 5.29TCr
+0.74%+2.66%-13.13%-6.34% 5.28TCr
-1.61%-3.23%+8.89%+64.05% 5.15TCr
+0.34%+4.46%+26.84%+79.54% 5.12TCr
+0.90%+5.62%+40.10%+103.30% 4.69TCr
Average +0.49%-3.75%-4.32%+35.18% 8.96TCr
Weighted average by Cap. +0.73%+1.41%+7.15%+51.30%

Financials

2026 *2027 *
Net sales 45Cr 4.57Cr 4.1Cr 3.79Cr 3.43Cr 6.41Cr 435.14Cr 6.49Cr 18Cr 227.7Cr 17Cr 17Cr 722.86Cr 48Cr 4.87Cr 4.37Cr 4.04Cr 3.66Cr 6.84Cr 464.14Cr 6.92Cr 19Cr 242.88Cr 18Cr 18Cr 771.04Cr
Net income -97.73L -10L -9L -8L -7L -13.83L -9.39Cr -14L -38.93L -4.91Cr -36.98L -36.2L -16Cr 85.96L 9L 8L 7L 7L 12.17L 8.26Cr 12.31L 34.24L 4.32Cr 32.53L 31.84L 14Cr
Net Debt 20Cr 1.98Cr 1.78Cr 1.64Cr 1.49Cr 2.78Cr 188.74Cr 2.82Cr 7.83Cr 99Cr 7.44Cr 7.28Cr 313.54Cr 18Cr 1.86Cr 1.67Cr 1.54Cr 1.4Cr 2.61Cr 177.19Cr 2.64Cr 7.35Cr 93Cr 6.98Cr 6.83Cr 294.36Cr
Projected Income Statement - Annual - Boule Diagnostics AB
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
29/26/29 SEK 1.035 +0.49% 30,101
28/26/28 SEK 1.030 -6.36% 2,80,076
27/26/27 SEK 1.100 -1.35% 1,36,981
26/26/26 SEK 1.115 -8.98% 8,05,179
23/26/23 SEK 1.225 -40.24% 13,66,449
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Boule Diagnostics AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.030SEK
Average target price
3.800SEK
Spread / Average Target
+268.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boule Diagnostics AB
  1. Stock Market
  2. Stocks
  3. BOUL Stock